|
|
|
|
| LEADER |
04466nmm a2200325 u 4500 |
| 001 |
EB000670350 |
| 003 |
EBX01000000000000000523432 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9783642694394
|
| 100 |
1 |
|
|a Culyer, A. J.
|e [editor]
|
| 245 |
0 |
0 |
|a Economic and Medical Evaluation of Health Care Technologies
|h Elektronische Ressource
|c edited by A. J. Culyer, B. Horisberger
|
| 246 |
3 |
1 |
|a Symposium April 1982, Wolfsberg, Switzerland
|
| 250 |
|
|
|a 1st ed. 1983
|
| 260 |
|
|
|a Berlin, Heidelberg
|b Springer Berlin Heidelberg
|c 1983, 1983
|
| 300 |
|
|
|a XXVI, 405 p
|b online resource
|
| 505 |
0 |
|
|a The Drug Cimetidine -- 18. Discussion of Paper by Weisbrod -- 19. A Review of the Epidemiological Development of Peptic Ulcers and an Evaluation of Duodenal Ulcers in the Federal Republic of Germany before and after Cimetidine -- 20. Discussion of Paper by Horisberger -- 21. A Review of the Macroeconomic Evaluation of Cimetidine -- 22. Discussion of Paper by Jönsson -- IV: Computerized Tomography of the Head -- 23. Clinical Questions Regarding a New Diagnostic Technology: A Case Study Using Computerized Tomography of the Head -- 24. Discussion of Paper by McNeil and Hanley -- 25. Economic Evaluation of CT Scanning of the Head: A Review -- 26. Discussion of Paper by Jonsson and Jonsson -- 27. The Evaluation of Computerized Tomography: A Review of Research Methods -- 28. Discussion of Paper by Russell -- 29. Macroeconomic Evaluation of Computerized Tomographic Scanning -- 30. Discussion of Paper by Wagner -- V: Envoi --
|
| 505 |
0 |
|
|a Overview -- 1. Evaluation and Medicine -- 2. Medical Evaluation of Health Care Technologies -- 3. Discussion of Paper by Balaban and Goldfarb -- 4. The Role of Economics in the Evaluation of Health Care Technologies -- 5. Discussion of Paper by Williams -- 6. Renal Replacement Therapy, Computerized Axial Tomography, and Cimetidine in Peptic Ulcer Disease -- II: Dialysis -- 7. A Review of the Clinical Evaluation of Dialysis -- 8. Discussion of Paper by Colombi -- 9. Economic Evaluation of Dialysis -- 10. Discussion of Paper by Pedersen -- 11. The Epidemiological Evaluation of Active Therapy of Patients with Renal Failure -- 12. Discussion of Paper by Schmitt and Klinkmann -- 13. Macroeconomic Evaluation of Kidney Dialysis -- 14. Discussion of Paper by Rutten -- III: Cimetidine -- 15. Clinical Evaluation of Cimetidine with Special Reference to Socioeconomic Effects -- 16. Discussion of Paper by Walan --
|
| 505 |
0 |
|
|a A Postscript -- 33. Glossary -- 34. References -- 35. Appendix. List of Members of Health Economists’ Study Group -- Index of Authors
|
| 653 |
|
|
|a Neurology
|
| 653 |
|
|
|a Biomedical engineering
|
| 653 |
|
|
|a Biomedical Engineering and Bioengineering
|
| 653 |
|
|
|a Neurology
|
| 700 |
1 |
|
|a Horisberger, B.
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-642-69439-4?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.8
|
| 520 |
|
|
|a All too frequently, the largest effective barrier to interdisciplinary communication is jargon. The symposium whose proceedings appear in the following pages sought, of course, to eliminate unnecessary and obscurantist jargon; but it sought also to do something far more ambitious - to confront the intellectual issues that are attached to the use of the word "evaluation" in medicine and health services. To this end a carefully selected group of experts in medicine, epidemiology, and health econom ics was invited to present papers. They were selected for their reputations either as conceptualizers or as empirical evaluators, or - the rarest breed of expert - as both. The context was to be empirical. Three procedures were selected that had been subject to evaluation but that posed rather different types of problem. The first was the treatment of renal failure by dialysis of various kinds. This has a relatively long history of evaluation, with a large literature, and particularly raises broad policy is sues within the health services of Western societies as to - the size of programmes to be provided; the type, location, and mix of treatments; the selection of patients to receive treatment; and the measurement of the success of various strategies. The second was the treatment of duodenal ulcer by a new species of drug - the hista mine Hrreceptor antagonists (specifically, cimetidine)
|